<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Integrin-linked kinase (ILK), an intracellular serine-threonine kinase, has been reported to be overexpressed in multiple types of human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The prognostic value of ILK in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, however, remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, expression of ILK in 25 paired primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples and adjacent noncancerous tissues were quantified using real-time PCR and Western blotting </plain></SENT>
<SENT sid="3" pm="."><plain>ILK protein expression was analyzed in 102 archived, paraffin-embedded <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples using immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>The correlation between ILK expression and clinicopathological factors was evaluated by the χ(2) test </plain></SENT>
<SENT sid="5" pm="."><plain>Patients' overall survival was analyzed by Kaplan-Meier method </plain></SENT>
<SENT sid="6" pm="."><plain>We found that both ILK <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression levels were significantly up-regulated in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples compared with their corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="7" pm="."><plain>Immunohistochemical analysis revealed relative high expression of ILK in 43 of 102 (42.2 %) primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples </plain></SENT>
<SENT sid="8" pm="."><plain>Statistical analysis showed a significant correlation of ILK expression with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> differentiation, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-node-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> stage </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> displaying high-level ILK expression showed significantly shorter overall survival (P = 0.028, log-rank test) </plain></SENT>
<SENT sid="10" pm="."><plain>More importantly, multivariate analysis indicated that high ILK protein expression was an independent prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients (P = 0.026) </plain></SENT>
<SENT sid="11" pm="."><plain>Taken together, our data suggest that ILK overexpression is associated with <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and a poor prognosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and may represent a novel potential prognostic marker for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>